Assenagon Asset Management
QTTB icon

Assenagon Asset Management’s Q32 Bio QTTB Stock Holding History

Assenagon Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,076
Closed -$22.7K – 1506
2023
Q4 		$22.7K Buy
2,076
+721
+53% +$10.5K ﹤0.01% 1391
2023
Q3 		$28.5K Sell
1,355
-1,396
-51% -$28.5K ﹤0.01% 1366
2023
Q2 		$43.8K Buy
2,751
+1,766
+179% +$31.7K ﹤0.01% 1309
2023
Q1 		$18.3K Buy
+985
New +$24.5K ﹤0.01% 1397
2022
Q3 		– Sell
-1,119
Closed -$40K – 1574
2022
Q2 		$40K Buy
+1,119
New +$38.2K ﹤0.01% 1429
2021
Q3 		– Sell
-27,022
Closed -$3.54M – 1453
2021
Q2 		$3.54M Buy
+27,022
New +$3.37M 0.01% 560

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Assenagon Asset Management's QTTB Position: Q1 2024 in Review

Assenagon Asset Management sold out of Q32 Bio (QTTB) in Q1 2024, closing a stake of 2,076 shares — an estimated $22.7K sold.

Assenagon Asset Management first reported a position in QTTB in Q2 2021 and held it in 6 quarters. The position peaked at $3.54M in Q2 2021. 39 funds tracked by Wall St. Rank hold QTTB as of Q1 2024.

  • Assenagon Asset Management reported no remaining Q32 Bio position as of Q1 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 2,076 Q32 Bio shares in Q1 2024, an estimated $22.7K.
  • Assenagon Asset Management first reported a position in Q32 Bio in Q2 2021 and held it in 6 quarters.
  • Assenagon Asset Management's Q32 Bio position peaked at $3.54M in Q2 2021.
  • 39 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2024.

Based on Assenagon Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.